Cargando…

The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis

BACKGROUND: Lateral flow urine lipoarabinomannan (LAM) tests could offer important new opportunities for the early detection of tuberculosis (TB). The currently licensed LAM test, Alere Determine TB LAM Ag (‘LF-LAM’), performs best in the sickest people living with HIV (PLHIV). However, the technolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricks, Saskia, Denkinger, Claudia M., Schumacher, Samuel G., Hallett, Timothy B., Arinaminpathy, Nimalan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732057/ https://www.ncbi.nlm.nih.gov/pubmed/33306694 http://dx.doi.org/10.1371/journal.pmed.1003466

Ejemplares similares

Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis
por: Ricks, Saskia, et al.
Publicado: (2021)

Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV
por: Kerkhoff, Andrew D., et al.
Publicado: (2020)

“SILVAMP TB LAM” Rapid Urine Tuberculosis Test Predicts Mortality in Patients Hospitalized With Human Immunodeficiency Virus in South Africa
por: Sossen, Bianca, et al.
Publicado: (2020)

Point-Of-Care Urine LAM Tests for Tuberculosis Diagnosis: A Status Update
por: Bulterys, Michelle A., et al.
Publicado: (2019)

Explaining age disparities in tuberculosis burden in Taiwan: a modelling study
por: Fu, Han, et al.
Publicado: (2020)

Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis
por: Nair, Sreenivas Achuthan, et al.
Publicado: (2016)

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers
por: Singhroy, Diane N., et al.
Publicado: (2020)

Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis
por: Silva, Sachin, et al.
Publicado: (2021)

The Potential Impact of Up-Front Drug Sensitivity Testing on India’s Epidemic of Multi-Drug Resistant Tuberculosis
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015)

The potential impact of vaccination on tuberculosis burden in India: A modelling analysis
por: Arinaminpathy, Nimalan, et al.
Publicado: (2023)

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients
por: Broger, Tobias, et al.
Publicado: (2019)

Predicting the impact of patient and private provider behavior on diagnostic delay for pulmonary tuberculosis patients in India: A simulation modeling study
por: Deo, Sarang, et al.
Publicado: (2020)

The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach
por: Mandal, Sandip, et al.
Publicado: (2020)

Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis
por: Reither, Klaus, et al.
Publicado: (2009)

Management of tuberculosis by healthcare practitioners in Pakistan: A systematic review
por: Braham, Christy A., et al.
Publicado: (2018)

The Global Drug Facility as an intervention in the market for tuberculosis drugs
por: Arinaminpathy, Nimalan, et al.
Publicado: (2015)

Diagnostic accuracy of 3 urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients
por: Broger, Tobias, et al.
Publicado: (2020)

Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis
por: Haraka, Frederick, et al.
Publicado: (2021)

User perspectives and preferences on a novel TB LAM diagnostic (Fujifilm SILVAMP TB LAM)–a qualitative study in Malawi and Zambia
por: Herrmann, Yannis, et al.
Publicado: (2022)

Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

Trade-offs between cost and accuracy in active case finding for tuberculosis: A dynamic modelling analysis
por: Cilloni, Lucia, et al.
Publicado: (2020)

Building a tuberculosis-free world while responding to the COVID-19 pandemic
por: Reid, Michael J A, et al.
Publicado: (2020)

Breakthrough of chemiluminescence-based LAM urine test beyond HIV-positive individuals: Clinical diagnostic value of pulmonary tuberculosis in the general population
por: Zhang, Yingxuan, et al.
Publicado: (2023)

Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies
por: Schumacher, Samuel G., et al.
Publicado: (2016)

Correction: Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine
por: Fu, Han, et al.
Publicado: (2021)

The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis
por: Cilloni, Lucia, et al.
Publicado: (2020)

Diagnostic Performance of the Fujifilm SILVAMP TB-LAM in Children with Presumptive Tuberculosis
por: Comella-del-Barrio, Patricia, et al.
Publicado: (2021)

fastlin: an ultra-fast program for Mycobacterium tuberculosis complex lineage typing
por: Derelle, Romain, et al.
Publicado: (2023)

Dynamics of Glycoprotein Charge in the Evolutionary History of Human Influenza
por: Arinaminpathy, Nimalan, et al.
Publicado: (2010)

Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review
por: Lawn, Stephen D
Publicado: (2012)

Rapid Urine LAM Testing Improves Diagnosis of Expectorated Smear-Negative Pulmonary Tuberculosis in an HIV-endemic Region
por: Drain, Paul K., et al.
Publicado: (2016)

Value of urine-based lipoarabinomannan (LAM) antigen tests for diagnosing tuberculosis in children: systematic review and meta-analysis
por: Seid, Getachew, et al.
Publicado: (2022)

Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis
por: Vesga, Juan F., et al.
Publicado: (2022)

Performance of Tuberculosis Molecular Bacterial Load Assay Compared to Alere TB-LAM in Urine of Pulmonary Tuberculosis Patients with HIV Co-Infections
por: Mapamba, Daniel Adon, et al.
Publicado: (2023)

Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data
por: Broger, Tobias, et al.
Publicado: (2020)

Modeling the impact of novel diagnostic tests on pediatric and extrapulmonary tuberculosis
por: Denkinger, Claudia M, et al.
Publicado: (2014)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Uptake of the lateral flow urine LAM test in Europe and Central Asia
por: Kraef, C., et al.
Publicado: (2022)

Evaluation of the diagnostic performance of laboratory-based c-reactive protein as a triage test for active pulmonary tuberculosis
por: Samuels, Thomas H. A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_id0e5ufji8quh3mcmv897u1921